FDA approves Takeda’s Mimrylo for blood cancer
Takeda’s Mimrylo received FDA approval to treat a blood cancer condition.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Takeda’s Mimrylo received FDA approval to treat a blood cancer condition.